新闻稿
全新的Cytiva在全球40 余个国家拥有约 1.6 万名员工,以超过 300 年的专业积淀,协助客户解决生物科技难题,更快更好地实现创新疗法的可及,变革人类健康的未来。
Read moreCytiva and the life sciences business of Pall complete integration to create a global innovation and solutions leader in biotechnology
Read more新闻稿
Cytiva supports BioCina with first GMP production and development facility for mRNA in Australia
Cytiva and the University of Adelaide are collaborating with BioCina, to expand its facility in Adelaide to manufacture mRNA-based vaccines and therapies.
Read more